MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


FTSE recovers to make gains on Friday with AstraZeneca leading the charge.

StockMarketWire.com

The FTSE 100 recovered from its lows to trade 0.1% higher at 6,969.81 by the close despite a drop in the S&P 500, which was down 0.6% to 4,187.64 by 4.50pm UK time.

High-street bank Barclays reported a sharp rise in first-quarter profit as 'materially' lower credit impairment charges offset a fall in income. For the three months through March, pre-tax profit jumped to a record £2.4 billion from £0.9 billion, while income slipped 6% to £5.9 billion year-on-year. However, its share price slipped in morning trading, down 7% to 175.5p.

Packaging firm Smurfit Kappa has revealed that corrugated volume growth in the first quarter was up approximately 7% in both Europe and the Americas, driving underlying revenue growth of 6% to €2,269 million (£1,972 million). It advanced 4.2% to £37.14

Pharmaceutical giant AstraZeneca reported a rise in the first quarter, driven by performance in new medicines across oncology and bioPharmaceuticals. For the first quarter of the year, revenue was up 15% to $7.32 billion as product sales increased 15% to $7.26 billion. It traded up 4.4% to £77.19 per share.

Another pharmaceutical firm, Hikma Pharmaceuticals, forecast its generics business to generate revenue toward the top end of guidance following a 'good' start to the new year that was in line with its expectations. It gained 3.2% to £24.40.

Flow control and instrumentation group Rotork has reported that performance in the period was in line with expectations amid global disruption.

The firm reports that revenue was up mid-single digits year-on-year on an organic constant currency basis, in part reflecting the weighting of first half 2020 sales to the second quarter. Its share price fell 2.6% to 347p.

Oil and gas company Diversified Gas & Oil said it had conditionally acquired certain Cotton Valley upstream assets and related facilities primarily in the state of Louisiana for $135 million. It was up 3.2% to 122.2p as it also announced strong Q1 numbers and a hike to the dividend.

Story provided by StockMarketWire.com